Surgery and adjunctive chemotherapy for invasive bladder cancer
- 4 March 2002
- journal article
- review article
- Published by Elsevier in Surgical Oncology
- Vol. 11 (1-2) , 55-63
- https://doi.org/10.1016/s0960-7404(02)00007-5
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Effect of p21WAF1/CIP1 Expression on Tumor Progression in Bladder CancerJNCI Journal of the National Cancer Institute, 1998
- p53 and treatment of bladder cancerNature, 1997
- Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.Journal of Clinical Oncology, 1996
- Accumulation of Nuclear p53 and Tumor Progression in Bladder CancerNew England Journal of Medicine, 1994
- P-glycoprotein expression in primary and metastatic transitional cell carcinoma of the bladderAnnals of Oncology, 1994
- Treatment of Carcinomatous Meningitis from Transitional Cell Carcinoma of the BladderBritish Journal of Urology, 1991
- Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneityBritish Journal of Cancer, 1990
- Initial Intravenous Cis-Platinum Therapy: Improved Management for Invasive High Risk Bladder Cancer?Journal of Urology, 1985
- EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURSThe Lancet, 1985
- Cis-diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancerCancer, 1981